US 12397062
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 12397062 (Muscle targeting complexes and uses thereof for treating dystrophinopathies) held by Dyne Therapeutics, Inc. expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Dyne Therapeutics, Inc.
- Grant date
- Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K38/00, A61K47/6807